Srf Limited
Case brief
What is this about?
The Competition Commission of India approved SRF Ltd.'s acquisition of DuPont's pharmaceutical-grade HFC 134a business, finding no appreciable adverse effect on competition due to lack of horizontal or vertical overlap.
What did the court decide?
Approved the combination under sub-section (1) of section 31 of the Competition Act, 2002.
What the court decided
A compact analysis
This page shows the compact analysis of this judgement. The full analysis — procedural history, issue-by-issue holdings with ratio and obiter, advocates, and paragraph-level evidence for every claim — is being added to the record in batches and will appear here when this judgement has been through it.
Fair Competition For Greater Good
COMPETITION COMMISSION OF INDIA (Combination Registration No. C-2015/12/347)
4th February 2016
Notice under Section 6 (2) of the Competition Act, 2002 given by SRF Ltd.
CORAM:
Mr. Devender Kumar Sikri Chairperson
Mr. S.L. Bunker Member
Mr. Sudhir Mital Member
Mr. Augustine Peter Member Mr. U.C. Nahta Member
Mr. M.S. Sahoo Member
Mr. G.P. Mittal Member
Legal Representative: M/s Vinod Dhall & tt&a
Issues for consideration
2 issues framed by the court
Whether the acquisition of Pharma grade HFC 134a business by SRF Ltd. from DuPont required approval.
Whether the combination was likely to have an appreciable adverse effect on competition in India.
Parties & counsel
- petitioner
Competition Commission of India
- applicant
SRF Ltd.
- applicant
E.I Du Pont De Nemours and Company
Coram
Case details
As recorded by the court registry
All orders in this case
2 orders share this CNR
- Order 1 — this page
- Order 2
Similar cases
Judgements on the same questions, provisions and authorities, from every court